Urologic Oncology Survivorship Guidelines: An Overview of the Evidence and the Current Implementation Gap

David Dan Nguyen, Christopher J.D. Wallis, Neil E. Fleshner, Quoc Dien Trinh, Zachary Klaassen, Rashid K. Sayyid

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Cancer survivorship is particularly significant for patients with urologic malignancies, who account for >25% of cancer survivors. The American Cancer Society has a guideline on survivorship care in prostate cancer and the American Urological Association has published a core curriculum on cancer survivorship in urologic cancers. However, there is a lack of high-quality evidence on survivorship strategies to inform guideline recommendations. Future efforts need to focus on producing high-quality survivorship research and on increasing appropriate resources to improve the implementation of survivorship care. Patient summary: There are few guidelines on survivorship care for patients with prostate, bladder, penile, or kidney cancer. More funding is needed for research into care for cancer survivors.

Original languageEnglish (US)
Pages (from-to)431-434
Number of pages4
JournalEuropean Urology Focus
Volume9
Issue number3
DOIs
StatePublished - May 2023

Keywords

  • Bladder cancer
  • Kidney cancer
  • Penile cancer
  • Prostate cancer
  • Survivorship
  • Testis cancer

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Urologic Oncology Survivorship Guidelines: An Overview of the Evidence and the Current Implementation Gap'. Together they form a unique fingerprint.

Cite this